BiotchPharma
Early access, named patient supply and market entry for Turkiye.
BiotchPharma supports innovative pharmaceutical and biotech companies with Early Access Programs, Named Patient Programs, Managed Access, clinical-trial interface, market access, distributorship and launch preparation.
10-15 years drug development realityEAP / NPP / MAP access pathwaysTurkiye local market execution
Leave No One Behind
Access to promising medicines when patients and physicians cannot wait.
BiotchPharma’s public service model is built around a clear principle: promising medicines should reach eligible patients through responsible, documented and locally managed pathways. This is especially important in rare, ultra-rare and life-threatening diseases where formal registration can lag behind urgent clinical need. For drug developers, BiotchPharma connects early access, clinical development awareness, institutional coordination, distribution readiness and commercial launch preparation in one local partner model.Official service focus
- Rare diseases, orphan drugs and specialty medicines
- Early Access, Named Patient, Managed Access and Expanded Access
- Compassionate Use, Post-Trial Access and Named Patient Import
- Market access, sales, marketing, KOL and KAM execution
- Local representation, distributorship and Turkiye launch preparation
Access Model
Structured routes before, during and after commercialization.
Named Patient Programs
Patient-level supply coordination under physician responsibility, including Named Patient Import and urgent product availability tracking.Managed and Expanded Access
Structured local access rules, stakeholder mapping, reporting expectations and operational control for eligible patients.Post-Trial Access
Continuity planning for patients who benefited from trial treatment and need responsible access after study completion.Clinical Research Interface
Clinical trials remain the strongest evidence path. Access programs protect continuity when trials are not enough.
BiotchPharma supports feasibility, study center and clinic selection, patient identification, central monitoring, data entry, SMO services, patient supply and clinical research archive coordination. When a patient cannot enter a trial, when a trial has ended, or when a medicine is not yet commercially available, BiotchPharma helps sponsors and physicians evaluate responsible access options.Institutional Coordination
Local execution across the real healthcare pathway.
BiotchPharma coordinates with the Turkish Ministry of Health, TITCK, Turkish Pharmacists Association, hospitals, clinics, CROs, depots, customs and local supply stakeholders. This local control helps developer companies enter Turkiye with stronger documentation, clearer reporting and fewer operational surprises.Market Entry
From first access signal to full local launch preparation.
01
Assess
Product profile, unmet need, clinical centers, patient pathway, physician interest and market opportunity.02
Prepare
EAP, NPP, MAP, Named Patient Import, Compassionate Use, pricing context and regulatory pathway readiness.03
Supply
Distributor, importer, depot, pharmacy, cold-chain, customs and documentation preparation.04
Launch
KOL engagement, advisory boards, congress participation, launch meetings, KAM planning, sales and marketing.Specialist Capabilities
Commercial and medical operations for high-need therapies.
Therapeutic focus
Rare diseases, ultra-rare diseases, oncology, hematology, genetic diseases, metabolic diseases, cardiology, neurology and specialty care.Medical network
KOL mapping, advisory boards, scientific boards, physician segmentation and disease-area communication.Commercial readiness
Country management, branch preparation, distributor coordination, market access, reimbursement readiness and value communication.Field execution
Sales team setup, Key Account Management, congress activities, launch meetings and brand-growth execution.Reporting discipline
Program tracking, sponsor updates, adverse-event routing, supply status and local process visibility.Partnership models
Licensing, co-marketing, co-promotion, early access collaboration, distributorship and strategic business development.Therapeutic Focus
Built for products where access, trust and timing matter.
Send Files To BiotchPharma
Share product, clinical or partnership details with the BiotchPharma team.
Secure Enquiry
Send a message with attachment
Your request will be routed to fatih.aktas@biotchpharma.com.
Partner With BiotchPharma